Literature DB >> 25771097

miRNAs in atherosclerotic plaque initiation, progression, and rupture.

Ioannis Andreou1, Xinghui Sun2, Peter H Stone2, Elazer R Edelman1, Mark W Feinberg3.   

Abstract

Atherosclerosis is a chronic immune-inflammatory disorder that integrates multiple cell types and a diverse set of inflammatory mediators. miRNAs are emerging as important post-transcriptional regulators of gene expression in most, if not all, vertebrate cells, and constitute central players in many physiological and pathological processes. Rapidly accumulating experimental studies reveal their key role in cellular and molecular processes related to the development of atherosclerosis. We review current evidence for the involvement of miRNAs in early atherosclerotic lesion formation and in plaque rupture and erosion. We conclude with a perspective on the clinical relevance, therapeutic opportunities, and future challenges of miRNA biology in understanding the pathogenesis of this complex disease.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  atherosclerosis; inflammation; miRNAs; shear stress; vulnerable plaque

Mesh:

Substances:

Year:  2015        PMID: 25771097      PMCID: PMC4424146          DOI: 10.1016/j.molmed.2015.02.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  110 in total

1.  MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation.

Authors:  Jing Zhou; Kuei-Chun Wang; Wei Wu; Shankar Subramaniam; John Y-J Shyy; Jeng-Jiann Chiu; Julie Y-S Li; Shu Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-02       Impact factor: 11.205

2.  miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling.

Authors:  Alberto Dávalos; Leigh Goedeke; Peter Smibert; Cristina M Ramírez; Nikhil P Warrier; Ursula Andreo; Daniel Cirera-Salinas; Katey Rayner; Uthra Suresh; José Carlos Pastor-Pareja; Enric Esplugues; Edward A Fisher; Luiz O F Penalva; Kathryn J Moore; Yajaira Suárez; Eric C Lai; Carlos Fernández-Hernando
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

3.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

4.  Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a.

Authors:  Wei Wu; Han Xiao; Andrés Laguna-Fernandez; Guadalupe Villarreal; Kuei-Chun Wang; Greg G Geary; Yuzhi Zhang; Wei-Chi Wang; Hsien-Da Huang; Jing Zhou; Yi-Shuan Li; Shu Chien; Guillermo Garcia-Cardena; John Y-J Shyy
Journal:  Circulation       Date:  2011-07-18       Impact factor: 29.690

5.  miR-125b regulates calcification of vascular smooth muscle cells.

Authors:  Claudia Goettsch; Martina Rauner; Nicole Pacyna; Ute Hempel; Stefan R Bornstein; Lorenz C Hofbauer
Journal:  Am J Pathol       Date:  2011-07-30       Impact factor: 4.307

6.  MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells.

Authors:  Chih-Wen Ni; Haiwei Qiu; Hanjoong Jo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-04       Impact factor: 4.733

7.  Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration.

Authors:  Ni Zhu; Dongze Zhang; Sifeng Chen; Xuemei Liu; Li Lin; Xinmiao Huang; Zhifu Guo; Juan Liu; Yanrong Wang; Wenjun Yuan; Yongwen Qin
Journal:  Atherosclerosis       Date:  2011-01-19       Impact factor: 5.162

8.  MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo.

Authors:  Daniele Torella; Claudio Iaconetti; Daniele Catalucci; Georgina M Ellison; Angelo Leone; Cheryl D Waring; Angela Bochicchio; Carla Vicinanza; Iolanda Aquila; Antonio Curcio; Gianluigi Condorelli; Ciro Indolfi
Journal:  Circ Res       Date:  2011-08-18       Impact factor: 17.367

9.  MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4.

Authors:  Ke Yang; Yu Song He; Xiao Qun Wang; Lin Lu; Qiu Jing Chen; Jing Liu; Zhen Sun; Wei Feng Shen
Journal:  FEBS Lett       Date:  2011-02-15       Impact factor: 4.124

10.  The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ.

Authors:  Feng Ma; Sheng Xu; Xingguang Liu; Qian Zhang; Xiongfei Xu; Mofang Liu; Minmin Hua; Nan Li; Hangping Yao; Xuetao Cao
Journal:  Nat Immunol       Date:  2011-07-24       Impact factor: 25.606

View more
  51 in total

Review 1.  MicroRNAs in dysfunctional adipose tissue: cardiovascular implications.

Authors:  Basak Icli; Mark W Feinberg
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

2.  MicroRNAs Regulate Cytokine Responses in Gingival Epithelial Cells.

Authors:  Steven C Y Chen; Christos Constantinides; Moritz Kebschull; Panos N Papapanou
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

Review 3.  Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy.

Authors:  Yu Zhang; Xinghui Sun; Basak Icli; Mark W Feinberg
Journal:  Endocr Rev       Date:  2017-04-01       Impact factor: 19.871

Review 4.  Atherosclerosis Is an Epigenetic Disease.

Authors:  Suowen Xu; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Trends Endocrinol Metab       Date:  2018-05-10       Impact factor: 12.015

5.  Biological function and mechanism of MALAT-1 in renal cell carcinoma proliferation and apoptosis: role of the MALAT-1-Livin protein interaction.

Authors:  Shaoan Chen; Pengpeng Ma; Ying Zhao; Bin Li; Shaobo Jiang; Hui Xiong; Zheng Wang; Hanbo Wang; Xunbo Jin; Chuan Liu
Journal:  J Physiol Sci       Date:  2016-09-21       Impact factor: 2.781

Review 6.  Targeting vascular (endothelial) dysfunction.

Authors:  Andreas Daiber; Sebastian Steven; Alina Weber; Vladimir V Shuvaev; Vladimir R Muzykantov; Ismail Laher; Huige Li; Santiago Lamas; Thomas Münzel
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

7.  Plasma circulating microRNAs in patients with stable coronary artery disease - Impact of different cardiovascular risk profiles and glomerular filtration rates.

Authors:  Karlis Trusinskis; Maris Lapsovs; Sandra Paeglite; Evija Knoka; Laima Caunite; Mairita Mazule; Ieva Briede; Sanda Jegere; Indulis Kumsars; Inga Narbute; Ilze Konrade; Andrejs Erglis; Aivars Lejnieks
Journal:  J Clin Transl Res       Date:  2021-04-16

Review 8.  MicroRNAs in Acute ST Elevation Myocardial Infarction-A New Tool for Diagnosis and Prognosis: Therapeutic Implications.

Authors:  Alina Ioana Scărlătescu; Miruna Mihaela Micheu; Nicoleta-Monica Popa-Fotea; Maria Dorobanțu
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

9.  Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1/2 and other parameters of vascular health.

Authors:  Alice Tamara; David J Coulson; Jevi Septyani Latief; Sherin Bakhashab; Jolanta U Weaver
Journal:  Stem Cell Res Ther       Date:  2021-05-14       Impact factor: 6.832

Review 10.  Application of targeted therapy strategies with nanomedicine delivery for atherosclerosis.

Authors:  Le-Chun Ou; Shan Zhong; Jing-Song Ou; Jin-Wei Tian
Journal:  Acta Pharmacol Sin       Date:  2020-05-26       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.